Margot Lindsay

Partner, London



Margot Lindsay is a partner in our global M&A and Corporate practice based in London.

She advises listed companies, private companies, financial sponsors and international corporates on international and domestic public and private M&A, joint ventures, reorganisations and general corporate advisory matters.

Margot has broad experience across a range of industries, with a particular focus on healthcare, energy, mining and metals, consumer and infrastructure.

Prior to joining White & Case, Margot worked for one of the UK’s magic circle law firms for 8 years.

Bars and Courts
England and Wales
University of Otago
New Zealand
University of Otago
New Zealand


Representation of Avon Rubber p.l.c. on its Listing Rule class 2 disposal of its Milkrite | interpuls business to Tetra Laval 

Representation of Avon Rubber p.l.c. on its Listing Rule class 2 acquisition of 3M's US ballistic protection business

Representation of Roark Capital Group and International Car Wash Group (ICWG) on the sale of ICWG to Driven Brands

Representation of MOL Hungarian Oil and Gas PLC on its US$1.57 billion acquisition of Chevron's 9.57 percent stake in the Azeri-Chirag-Gunashli oil field in the Caspian Sea off Azerbaijan and an effective 8.90 percent interest in the Baku-Tbilisi-Ceyhan pipeline running across Azerbaijan, Georgia and Türkiye

Representation of ASX and AIM-listed European Metals, in the sale of the majority of its Czech Cinovec Lithium Project to Czech-utility CEZ, including associated shareholder approvals and joint venture arrangements with CEZ Representation of Allianz Capital Partners on its co-investment in GasNet, the Czech Republic’s largest gas distribution network business, as part of a consortium of investors led by Macquarie Infrastructure and Real Assets (MIRA)

Representation of J Sainsbury plc on its proposed £15 billion merger with Asda*

Representation of Reckitt Benckiser on the US$17.9 billion acquisition of Mead Johnson Nutrition Company*

Representation of UBM plc on its takeover by Informa plc for £3.8 billion*

Representation of Takeda Pharmaceuticals on the US$578 million sale of its global respiratory product portfolio to AstraZeneca*

* Experience prior to joining White & Case